Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

Tonix Pharmaceuticals (NASDAQ: TNXP) will implement a 1-for-100 reverse stock split, effective at <a target=_blank href= ...

Tonix Pharmaceuticals (NASDAQ: TNXP) announced the promotion of Siobhan Fogarty to chief technical officer. Fogarty, who joined Tonix in 2016, previo ...

Germany's Atmos Space Cargo announced today (Feb. 5) that its first Phoenix reentry capsule will fly on SpaceX 's Bandwagon 3 rideshare mission. A Falcon 9 rocket will launch Bandwagon 3 no earlier ...

Investors interested in arranging a meeting with the Company’s management during the conference can register on the BIO CEO & Investor Conference website here.

Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product DevelopmentTonix is Preparing for Potential Launch ...

Caring for HIV-positive mothers after childbirth is critical, particularly when discussing the health of both the mother and ...

Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product Development Tonix is Preparing for Potential Launch of TNX-102 SL for the management of fibromyalgia with ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline ...

Updated recommendations were issued by the IAS-USA regarding the use of ART for treatment and prevention of HIV in adult populations.

The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...